Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Rossmax International's
Operating Income
for the
three
months ended in Dec. 2025 was NT$-29 Mil. Rossmax International's Interest Expense for the
three
months ended in Dec. 2025 was NT$-7 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Rossmax International's Interest Coverage or its related term are showing as below:
ROCO:4121's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 15.875 * Ranked among companies with meaningful Interest Coverage only.
Rossmax International (ROCO:4121) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Rossmax International Interest Coverage Related Terms
Rossmax International Interest Coverage Historical Data
* Premium members only.
The historical data trend for Rossmax International's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ROCO:4121 vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Rossmax International's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossmax International Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rossmax International's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Rossmax International's Interest Coverage falls into.
Rossmax International Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Rossmax International did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Rossmax International (ROCO:4121) has a Interest Coverage of 0 (At Loss) as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Rossmax International and its competitors. According to the industry distribution chart, Rossmax International ranks #999999 out of 466 companies in the Medical Devices & Instruments industry.
Is Rossmax International's Interest Coverage too high?
Rossmax International's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Rossmax International ranks #999999 out of 466 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Rossmax International has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rossmax International's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Rossmax International ranks #999999 out of 466 companies for Interest Coverage. This places Rossmax International in the lower half of its industry. The industry median Interest Coverage is 15.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Rossmax International and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossmax International's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossmax International stock overvalued right now?
Based on GuruFocus' analysis, Rossmax International (ROCO:4121) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$19.05, compared to a current price of NT$13.80 — trading 27.6% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Rossmax International's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Rossmax International (ROCO:4121), the current Interest Coverage is 0 (At Loss) as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossmax International (ROCO:4121) Overvalued in 2026?
Based on GuruFocus' analysis, Rossmax International stock appears to be undervalued.
The current stock price of NT$13.80 is trading 27.6% below its estimated GF Value™ of NT$19.05.
GuruFocus considers Rossmax International to be Modestly Undervalued.
Key valuation signals for ROCO:4121:
Interest Coverage: 0 (At Loss)
GF Value™: NT$19.05 vs. price of NT$13.80 (27.6% below fair value)
No single metric tells the full story. See the ROCO:4121 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossmax International Ltd is mainly engaged in medical equipment manufacturing, wholesale or retail, and the medicine and cosmetics channels. The group has three reportable departments: the medical device department, the retail channel department, and the investment department. The medical device department manufactures various types of medical supplies. The retail channel department is engaged in the retail of cosmetics, medical equipment, food products, and beverages. Geographically, it derives key revenue from the Taiwan region and the rest from Iraq, Algeria, the U.S.A, the U.A.E, Malaysia, Iran, Kazakhstan, South Korea, Norway, Croatia, Tunisia, and Other.
58GF Score
Get the complete analysis for ROCO:4121
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4121 has been successfully added to your 
